Kristen Williams

CIK: 0001296965

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (37.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (37.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PCRX

Pacira BioSciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

PCRX
Pacira BioSciences, Inc.
Jun 4, 2026
Sale(S)
Direct
10.3K shares at avg. $22.27$228K
PCRX
Pacira BioSciences, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
8.5K shares at avg. $22.32$190K
PCRX
Pacira BioSciences, Inc.
Feb 11, 2026
Award(A)
Direct
54.5K shares-
PCRX
Pacira BioSciences, Inc.
Feb 2, 2026
Sale(S)
Direct
13.1K shares at avg. $20.53$270K
PCRX
Pacira BioSciences, Inc.
Jan 30, 2026
Tax Payment(F)
Direct
17.1K shares at avg. $20.54$352K
PCRX
Pacira BioSciences, Inc.
Jun 4, 2025
Sale(S)
Direct
14.4K shares at avg. $26.24$377K
PCRX
Pacira BioSciences, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
6.2K shares at avg. $26.40$163K
PCRX
Pacira BioSciences, Inc.
Feb 1, 2025
Award(A)
Direct
79.2K shares-

		Type	Shares	Price		Ownership
Jun 4, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	10,259	$22.27	$228,468	Direct
Jun 3, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	8,528	$22.32	$190,345	Direct
Feb 11, 2026	PCRX Pacira BioSciences, Inc.	Award(A)	54,546	-	$0	Direct
Feb 2, 2026	PCRX Pacira BioSciences, Inc.	Sale(S)	13,137	$20.53	$269,703	Direct
Jan 30, 2026	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	17,134	$20.54	$351,932	Direct
Jun 4, 2025	PCRX Pacira BioSciences, Inc.	Sale(S)	14,376	$26.24	$377,226	Direct
Jun 3, 2025	PCRX Pacira BioSciences, Inc.	Tax Payment(F)	6,162	$26.40	$162,677	Direct
Feb 1, 2025	PCRX Pacira BioSciences, Inc.	Award(A)	79,200	-	-	Direct

1-8 of 8 transactions

About WILLIAMS KRISTEN

WILLIAMS KRISTEN (SEC CIK 0001296965) files insider reports with the SEC as Chief Administrative Officer of Pacira BioSciences, Inc. (PCRX).

Signal8 holds 5 ownership filings by WILLIAMS KRISTEN, all Form 4s, filed between Feb 4, 2025 and Jun 5, 2026. Those filings report 8 transactions, from Feb 1, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WILLIAMS KRISTEN's filings is in BRISBANE, CA.

Recent filings by WILLIAMS KRISTEN

Jun 4, 2026: Open-market sale of PCRX shares (Form 4, code S).
Jun 3, 2026: Tax withholding of PCRX shares (Form 4, code F).
Feb 11, 2026: Grant or award of PCRX shares (Form 4, code A).
Feb 2, 2026: Open-market sale of PCRX shares (Form 4, code S).
Jan 30, 2026: Tax withholding of PCRX shares (Form 4, code F).

Other insiders filing for Pacira BioSciences, Inc. (PCRX)

RIKER LAUREN, Senior Vice President, Finance
SLONIN JONATHAN, Chief Medical Officer
Hirawat Samit, Director
CHRISTIE CHRISTOPHER, Director
WIGGANS THOMAS G, Director
Young Alethia, Director

How to read Form 4 transaction codes